Recently Chrysovergis et al. reported that GDF-15 is a novel therapeutic target in preventing and treating obesity and insulin resistance by modulating metabolic activity through increased expression of key thermogenic and lipolytic genes in brown adipose tissue (BAT) and white adipose tissue (WAT) [61]. The gene discussed is GDF15; the disease is obesity due to melanocortin 4 receptor deficiency.